99 related articles for article (PubMed ID: 19619018)
1. Efficacy of intravenous infusion of doripenem.
Restrepo MI
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S17-27. PubMed ID: 19619018
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
[TBL] [Abstract][Full Text] [Related]
3. Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators.
Kollef MH; Nathwani D; Merchant S; Gast C; Quintana A; Ketter N
Crit Care; 2010; 14(3):R84. PubMed ID: 20459721
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
Réa-Neto A; Niederman M; Lobo SM; Schroeder E; Lee M; Kaniga K; Ketter N; Prokocimer P; Friedland I
Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
[TBL] [Abstract][Full Text] [Related]
5. Safety of intravenous infusion of doripenem.
Redman R; File TM
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S28-35. PubMed ID: 19619019
[TBL] [Abstract][Full Text] [Related]
6. Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
Merchant S; Gast C; Nathwani D; Lee M; Quintana A; Ketter N; Friedland I; Ingham M
Clin Ther; 2008 Apr; 30(4):717-33. PubMed ID: 18498921
[TBL] [Abstract][Full Text] [Related]
7. A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
Mustafa M; Chan WM; Lee C; Harijanto E; Loo CM; Van Kinh N; Anh ND; Garcia J
Int J Antimicrob Agents; 2014 Apr; 43(4):353-60. PubMed ID: 24636429
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.
Kollef MH; Chastre J; Clavel M; Restrepo MI; Michiels B; Kaniga K; Cirillo I; Kimko H; Redman R
Crit Care; 2012 Nov; 16(6):R218. PubMed ID: 23148736
[TBL] [Abstract][Full Text] [Related]
9. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ; Lancaster JW
Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
Jenkins SG; Fisher AC; Peterson JA; Nicholson SC; Kaniga K
Curr Med Res Opin; 2009 Dec; 25(12):3029-36. PubMed ID: 19849650
[TBL] [Abstract][Full Text] [Related]
11. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
12. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs.
Duszynska W; Taccone FS; Switala M; Hurkacz M; Kowalska-Krochmal B; Kübler A
Int J Antimicrob Agents; 2012 Feb; 39(2):153-8. PubMed ID: 22154855
[TBL] [Abstract][Full Text] [Related]
14. [Review of the effectiveness of an empirical antibiotic therapy in suspected ventilator-associated pneumonia].
Kozioł-Montewka M; Jaworska-Gromaszek I; Biernacka J; Pluta A; Niedźwiadek J; Kaczor D; Ligięza J; Rudzki S
Anestezjol Intens Ter; 2011; 43(3):163-8. PubMed ID: 22011920
[TBL] [Abstract][Full Text] [Related]
15. Doripenem: a new carbapenem in the treatment of nosocomial infection.
Mandell L
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S1-3. PubMed ID: 19619016
[TBL] [Abstract][Full Text] [Related]
16. Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
Joshi M; Metzler M; McCarthy M; Olvey S; Kassira W; Cooper A
Respir Med; 2006 Sep; 100(9):1554-65. PubMed ID: 16487695
[TBL] [Abstract][Full Text] [Related]
17. Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
McGarry LJ; Merchant S; Nathwani D; Pawar V; DeLong K; Thompson D; Akhras K; Ingham M; Weinstein MC
J Med Econ; 2010 Mar; 13(1):142-7. PubMed ID: 20136579
[TBL] [Abstract][Full Text] [Related]
18. Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion.
Lorente L; Jiménez A; Martín MM; Iribarren JL; Jiménez JJ; Mora ML
Int J Antimicrob Agents; 2009 May; 33(5):464-8. PubMed ID: 19150225
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia.
Zilberberg MD; Mody SH; Chen J; Shorr AF
Surg Infect (Larchmt); 2010 Oct; 11(5):409-17. PubMed ID: 20666580
[TBL] [Abstract][Full Text] [Related]
20. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
